Inventor · disambiguated record
Robert G. Gentles
Also filed as: GENTLES ROBERT · GENTLES ROBERT G · GENTLES ROBERT GERARD
35 granted patents·7 pending applications·468 citations·filing 1989–2021
97Inventor score
Files withBRISTOL MYERS SQUIBB CO27VIIV HEALTHCARE UK NO 5 LTD3GENZYME CORP2ICOS CORP2MARTIN SCOTT W2
Top patents by PatentIndex Score
42 records- 0198US7153848B2Inhibitors of HCV replicationBRISTOL MYERS SQUIBB CO·Filed 2005·Granted Dec 26, 2006·90 cites·32 claims
- 0297US7348425B2Inhibitors of HCV replicationBRISTOL MYERS SQUIBB CO·Filed 2006·Granted Mar 25, 2008·59 cites·1 claims
- 0395US7521443B2Cyclopropyl fused indolobenzazepine HCV NS5B inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2007·Granted Apr 21, 2009·13 cites·5 claims
- 0495US7452876B2Cyclopropyl fused indolobenzazepine HCV NS5B inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2007·Granted Nov 18, 2008·21 cites·14 claims
- 0593US7485633B2Cyclopropyl fused indolobenzazepine HCV NS5B inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2007·Granted Feb 3, 2009·20 cites·3 claims
- 0692US7473688B2Indolobenzazepine HCV NS5B inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2006·Granted Jan 6, 2009·26 cites·15 claims
- 0792US7456166B2Cyclopropyl fused indolobenzazepine HCV NS5B inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2007·Granted Nov 25, 2008·24 cites·17 claims
- 0892US7399758B2Cyclopropyl fused indolobenzazepine HCV NS5B inhibitorsMEANWELL NICHOLAS A·Filed 2006·Granted Jul 15, 2008·28 cites·13 claims
- 0991US7521442B2Cyclopropyl fused indolobenzazepine HCV NS5B inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2007·Granted Apr 21, 2009·18 cites·12 claims
- 1091US7521441B2Cyclopropyl fused indolobenzazepine HCV NS5B inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2007·Granted Apr 21, 2009·18 cites·12 claims
- 1190US7521444B2Compounds for the treatment of hepatitis CBRISTOL MYERS SQUIBB CO·Filed 2008·Granted Apr 21, 2009·17 cites·12 claims
- 1289US7538102B2Compounds for the treatment of Hepatitis CBRISTOL MYERS SQUIBB CO·Filed 2008·Granted May 26, 2009·16 cites·13 claims
- 1388US10669272B2Substituted naphthyridinone compounds useful as T cell activatorsBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Jun 2, 2020·4 cites·13 claims
- 1488US7541351B2Compounds for the treatment of hepatitis CBRISTOL MYERS SQUIBB CO·Filed 2008·Granted Jun 2, 2009·11 cites·11 claims
- 1588US6559140B2Cyclic and bicyclic diamino histamine-3 receptor antagonistsABBOTT LAB·Filed 2001·Granted May 6, 2003·24 cites·21 claims
- 1687US7541353B2Compounds for the treatment of hepatitis CBRISTOL MYERS SQUIBB CO·Filed 2008·Granted Jun 2, 2009·11 cites·12 claims
- 1785US11866430B2Naphthyridinone compounds useful as T cell activatorsBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Jan 9, 2024·3 cites·11 claims
- 1885US7547690B2Compounds for the treatment of Hepatitis CBRISTOL MYERS SQUIBB CO·Filed 2008·Granted Jun 16, 2009·8 cites·13 claims
- 1984US6787542B2Aryl phenylheterocyclyl sulfide derivatives and their use as cell adhesion-inhibiting anti-inflammatory and immune-suppressive agentsICOS CORP·Filed 2001·Granted Sep 7, 2004·19 cites·27 claims
- 2080US7652004B2Compounds for the treatment of hepatitis CBRISTOL MYERS SQUIBB CO·Filed 2008·Granted Jan 26, 2010·4 cites·17 claims
- 2178US8133884B2Compounds for the treatment of hepatitis CMARTIN SCOTT W·Filed 2009·Granted Mar 13, 2012·5 cites·13 claims
- 2270US2009162318A1Cyclopropyl Fused Indolobenzazepine HCV NS5B InhibitorsBRISTOL MYERS SQUIBB CO·Filed 2009·Application pending·0 cites
- 2369US7129247B2Aryl phenylheterocyclyl sulfide derivatives and their use as cell adhesion-inhibiting anti-inflammatory and immune-suppressive agentsICOS CORP·Filed 2004·Granted Oct 31, 2006·3 cites·26 claims
- 2468US2013171098A1Cyclopropyl Fused Indolobenzazepine HCV NS5B InhibitorsBRISTOL MYERS SQUIBB CO·Filed 2013·Application pending·0 cites
- 2567US11713316B2Substituted naphthyridinone compounds useful as T cell activatorsBRISTOL MYERS SQUIBB CO·Filed 2021·Granted Aug 1, 2023·0 cites·11 claims
- 2667US2014045816A1Cyclopropyl Fused Indolobenzazepine HCV NS5B InhibitorsBRISTOL MYERS SQUIBB CO·Filed 2013·Application pending·0 cites
- 2764US2014186299A1Cyclopropyl Fused Indolobenzazepine HCV NS5B InhibitorsBRISTOL MYERS SQUIBB CO·Filed 2014·Application pending·0 cites
- 2861US10954238B1Substituted naphthyridinone compounds useful as T cell activatorsBRISTOL MYERS SQUIBB CO·Filed 2020·Granted Mar 23, 2021·0 cites·11 claims
- 2961US2011311480A1Cyclopropyl Fused Indolobenzazepine HCV NS5B InhibitorsBENDER JOHN A·Filed 2011·Application pending·0 cites
- 3060US6008398ANon-nucleotide phosphorus ester oligomersGENZYME CORP·Filed 1996·Granted Dec 28, 1999·8 cites·34 claims
- 3159US5919965ANon-nucleotide phosphorus ester oligomersGENZYME CORP·Filed 1995·Granted Jul 6, 1999·8 cites·5 claims
- 3254US11964973B2Substituted bicyclic compounds useful as T cell activatorsBRISTOL MYERS SQUIBB CO·Filed 2020·Granted Apr 23, 2024·0 cites·11 claims
- 3354US2023061608A1Substituted quinolinonyl piperazine compounds useful as t cell activatorsBRISTOL MYERS SQUIBB CO·Filed 2020·Application pending·0 cites
- 3451US8143243B2Compounds for the treatment of hepatitis CMARTIN SCOTT W·Filed 2009·Granted Mar 27, 2012·0 cites·3 claims
- 3551US2023089255A1Combinations of dgk inhibitors and checkpoint antagonistsBRISTOL MYERS SQUIBB CO·Filed 2020·Application pending·0 cites
- 3645US10035760B2Inhibitors of human immunodeficiency virus replicationVIIV HEALTHCARE UK NO 5 LTD·Filed 2014·Granted Jul 31, 2018·0 cites·16 claims
- 3743US4959992APiezo-electric transducer test apparatusMARCONI CO LTD·Filed 1989·Granted Oct 2, 1990·7 cites·6 claims
- 3842US9855230B2Inhibitors of human immunodeficiency virus replicationVIIV HEALTHCARE UK (NO 5) LTD·Filed 2015·Granted Jan 2, 2018·0 cites·18 claims
- 3939US8354548B2Glycine chroman-6-sulfonamides for use as inhibitors of diacylglycerol lipaseBRISTOL MYERS SQUIBB CO·Filed 2011·Granted Jan 15, 2013·0 cites·12 claims
- 4037US10221129B2Inhibitors of human immunodeficiency virus replicationVIIV HEALTHCARE UK NO 5 LTD·Filed 2016·Granted Mar 5, 2019·0 cites·20 claims
- 4134US5327771ALoading probe for use in testing transducersGEC FERRANTI DEFENCE SYST·Filed 1992·Granted Jul 12, 1994·3 cites·5 claims
- 4231US8404741B2Glycine chroman-6-sulfonamides for use as inhibitors of diacylglycerol lipaseCHUPAK LOUIS S·Filed 2011·Granted Mar 26, 2013·0 cites·12 claims
Join the waitlist — get patent alerts
Get an alert when Robert G. Gentles files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →